These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 2291368

  • 1. [Sialic acid concentrations in blood samples as well as in cyst and peritoneal fluid in patients with ovarian cysts and cystic ovarian tumors].
    Strache RR, Büttner HH, Göcze PM, Briese V.
    Zentralbl Gynakol; 1990; 112(23):1445-53. PubMed ID: 2291368
    [Abstract] [Full Text] [Related]

  • 2. [Determination of N-acetylneuraminic acid for the differential diagnosis of cystic ovarian tumors].
    Donat H, Bernstein L, Schenk H, Erbstösser E, Rosé A.
    Arch Geschwulstforsch; 1989; 59(2):113-20. PubMed ID: 2719531
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Correlation of total (TSA) and lipid and bound (LSA) sialic acid levels with cytology of cyst or body fluids in cancer patients.
    Chondros K, Dapolla V, Stringou E, Petiniki M, Vakouftsi M, Kakari S.
    Anticancer Res; 1991; 11(6):2103-6. PubMed ID: 1776847
    [Abstract] [Full Text] [Related]

  • 6. CA 125 in ovarian cysts, serous effusions and peritoneal washings: immunocytochemical expression.
    Carico E, Chicchirichi R, Atlante M, Giovagnoli M, Vecchione A.
    Anticancer Res; 1995; 15(2):631-4. PubMed ID: 7763049
    [Abstract] [Full Text] [Related]

  • 7. [CEA determination in aspired fluid of cystic ovarian tumors and ovarian cysts and in ascites and serum samples of patients with ovarian tumors].
    Kunze M, Büttner HH, Strache RR, Voss P, Briese V, Schrodt U.
    Zentralbl Gynakol; 1988; 110(16):1006-12. PubMed ID: 3188713
    [Abstract] [Full Text] [Related]

  • 8. Calgranulins in cystic fluid and serum from patients with ovarian carcinomas.
    Ott HW, Lindner H, Sarg B, Mueller-Holzner E, Abendstein B, Bergant A, Fessler S, Schwaerzler P, Zeimet A, Marth C, Illmensee K.
    Cancer Res; 2003 Nov 01; 63(21):7507-14. PubMed ID: 14612552
    [Abstract] [Full Text] [Related]

  • 9. Gonadotropin (LH, FSH) levels in serum and cyst fluid in epithelial tumors of the ovary.
    Chudecka-Głaz A, Rzepka-Górska I, Kosmowska B.
    Arch Gynecol Obstet; 2004 Nov 01; 270(3):151-6. PubMed ID: 12883823
    [Abstract] [Full Text] [Related]

  • 10. Cytologic examination of ovarian cyst fluid for the distinction between benign and malignant tumors.
    Moran O, Menczer J, Ben-Baruch G, Lipitz S, Goor E.
    Obstet Gynecol; 1993 Sep 01; 82(3):444-6. PubMed ID: 8355950
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Vascular endothelial growth factor levels in ovarian cyst fluid correlate with malignancy.
    Hazelton D, Nicosia RF, Nicosia SV.
    Clin Cancer Res; 1999 Apr 01; 5(4):823-9. PubMed ID: 10213218
    [Abstract] [Full Text] [Related]

  • 13. [Differential diagnosis of cystic ovarian tumors by determination of estradiol in cystic aspirate].
    Ammann M, Hänggi W, Baumann U, Keller PJ.
    Geburtshilfe Frauenheilkd; 1991 Jun 01; 51(6):481-3. PubMed ID: 1889731
    [Abstract] [Full Text] [Related]

  • 14. Vascular endothelial growth factor and its soluble receptor in benign and malignant ovarian tumors.
    Artini PG, Ruggiero M, Monteleone P, Carpi A, Cristello F, Cela V, Genazzani AR.
    Biomed Pharmacother; 2008 Jun 01; 62(6):373-7. PubMed ID: 18037256
    [Abstract] [Full Text] [Related]

  • 15. N-acetyl resonances in in vivo and in vitro NMR spectroscopy of cystic ovarian tumors.
    Kolwijck E, Engelke UF, van der Graaf M, Heerschap A, Blom HJ, Hadfoune M, Buurman WA, Massuger LF, Wevers RA.
    NMR Biomed; 2009 Dec 01; 22(10):1093-9. PubMed ID: 19593761
    [Abstract] [Full Text] [Related]

  • 16. Clinical significance of combined use of macrophage colony-stimulating factor and squamous cell carcinoma antigen as a selective diagnostic marker for squamous cell carcinoma arising in mature cystic teratoma of the ovary.
    Suzuki M, Tamura N, Kobayashi H, Ohwada M, Terao T, Sato I.
    Gynecol Oncol; 2000 Jun 01; 77(3):405-9. PubMed ID: 10831350
    [Abstract] [Full Text] [Related]

  • 17. Soluble receptor for urokinase plasminogen activator in both full-length and a cleaved form is present in high concentration in cystic fluid from ovarian cancer.
    Wahlberg K, Høyer-Hansen G, Casslén B.
    Cancer Res; 1998 Aug 01; 58(15):3294-8. PubMed ID: 9699658
    [Abstract] [Full Text] [Related]

  • 18. Comparative analysis of CA125, tissue polypeptide specific antigen, and soluble interleukin-2 receptor alpha levels in sera, cyst, and ascitic fluids from patients with ovarian carcinoma.
    Sedlaczek P, Frydecka I, Gabryś M, Van Dalen A, Einarsson R, Harłozińska A.
    Cancer; 2002 Nov 01; 95(9):1886-93. PubMed ID: 12404282
    [Abstract] [Full Text] [Related]

  • 19. Peritoneal fluid lactate dehydrogenase in ovarian cancer.
    Schneider D, Halperin R, Langer R, Bukovsky I, Herman A.
    Gynecol Oncol; 1997 Sep 01; 66(3):399-404. PubMed ID: 9299252
    [Abstract] [Full Text] [Related]

  • 20. Increased concentrations of neopterin in plasma, ascites and ovarian cyst fluid in malignant tumours compared with benign ovarian tumours.
    Haeger M, Swahn M, Hahlin M, Horvath G, Bengtsson A.
    Anticancer Res; 1996 Sep 01; 16(5B):3189-92. PubMed ID: 8967734
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.